# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001564590-22-013239
Filing Date
2022-04-01
Accepted
2022-04-01 16:30:37
Documents
5
Period of Report
2022-05-27

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | rlay-pre14a_20220527.htm | PRE 14A | 1774572
2 | GRAPHIC | gfsfwujazsfd000004.jpg | GRAPHIC | 436335
3 | GRAPHIC | gfsfwujazsfd000002.jpg | GRAPHIC | 31128
4 | GRAPHIC | gfsfwujazsfd000003.jpg | GRAPHIC | 560287
5 | GRAPHIC | gfsfwujazsfd000001.jpg | GRAPHIC | 31128
| Complete submission text file | 0001564590-22-013239.txt |  | 3234346

Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39385 | Film No.: 22798721
SIC: 2836 Biological Products, (No Diagnostic Substances)